№11 / 2021

REVIEWS
F.V. Moiseenko (1, 2)
Hope or error: can combinations of EGFR tyrosine kinase inhibitors and other drugs replace monotherapy? 		13-20
E.A. Kobyakova (1), D.Yu. Usachev (2), O.V. Absalyamova (2), N.G. Kobyakov (3), K.S. Lodygina (2), A.Yu. Belyaev (2), Yu.Yu. Trunin (2), A.S. Belyashova (2), G.L. Kobyakov (2)
Response assessment in neuro-oncology (RANO) criteria: application in clinical research and routine practice 		21-33
D.A. Sychev (1), O.D. Ostroumova (1), M.S. Chernyaeva (2), A.P. Pereverzev (1), A.I. Kochetkov (1), T.M. Ostroumova (3), M.V. Klepikova (1), E.Yu. Ebzeeva (1), V.A. De (1)
Risk factors of drug-induced diseases. Part 1. Classification, non-modified risk factors 		34-46
A.S. Kulakova, D.L. Bentsion, V.G. Elishev, V.A. Vetrov
Systemic alpha-radiotherapy with radium-223 (Xofigo) in patients with metastatic castration-resistant prostate cancer (mCRPC). Clinical experience of using the drug in Sverdlovsk Regional Oncological Dispensary, Yekaterinburg 		47-51
A.I. Semenova (1), S.A. Protsenko (1), G.M. Teletaeva (1), D.Kh. Latipova (1), A.V. Novik (1, 2)
Neoadjuvant immunotherapy for non-small cell lung cancer 		52-56
L.G. Zhukova (1), E.V. Artamonova (2, 3, 4), I.P. Ganshina (4), I.V. Kolyadina (5), K.A. Vorontsova (1), O.V. Sekhina (1), K.S. Grechukhina (1)
Dual HER2 blockade with pertuzumab+trastuzumab on the eve of a new era in the treatment of HER2-positive breast cancer 		57-65
M.A. Dzhelyalova, V.F. Semiglazov
Ways to improve endocrine therapy in postmenopausal women with ER+/HER2- breast cancer 		66-69
ORIGINAL ARTICLES
G.A. Khakimov (1, 2), B.B. Negmadzhanov (3), G.G. Khakimova (1, 2), M.N. Tashmetov (1), Kh.U. Musurmonov (1, 2), Sh.G. Khakimova (1, 4), Sh.Sh. Kadyrov (1, 2), Sh.T. Usmanova (1, 2)
Radical hysterectomy with adequate dissection of areas of possible metastasis in locally advanced cervical cancer 		70-76
D.V. Ivashchenko (1, 2), N.I. Buromskaya (3), P.V. Shimanov (3), R.V. Deich (3), I.V. Dorina (3), M.I. Nastovich (3), K.A. Akmalova (1), A.A. Kachanova (1), E.A. Grishina (1), L.M. Savchenko (1), Yu.S. Shevchenko (1), D.A. Sychev (1)
Pharmacogenetic predictors of the efficacy and safety of antipsychotics in adolescents with an acute psychotic episode 		77-83
D.A. Sychev (1), O.D. Ostroumova (1, 2), A.I. Kochetkov (1), A.P. Pereverzev (1), T.M. Ostroumova (2), M.V. Klepikova (1), E.Yu. Ebzeeva (1)
Medication errors as risk factor for drug-induced diseases 		84-94
S.V. Khokhlova
Clinical case of treatment of patient with HRD-positive ovarian cancer 		96-104
M.M. Konstantinova (1), L.I. Kuzina (2)
Will our clinical practice change with the availability of new diagnostic methods, drug therapy and assessment of its effectiveness? Clinical case: hormone receptor-positive, HER2-negative metastatic breast cancer 		105-110
Kh.I. Dzhumaniezov (1, 2), G.A. Khakimov (1, 2), G.G. Khakimova (1, 2), Sh.T. Usmanova (1, 2), Sh.G. Khakimova (1, 3), Sh.Sh. Kadyrov (1, 2)
Clinical observation of successful treatment of retroperitoneal nephroblastoma 		111-114
115

Бионика Медиа